2c and d). However, in response to

the peptide pools of RD15 and its individual selleck products ORFs, PBMC of TB patients showed weak responses in IFN-γ assays (<40% positive responders) (Fig. 2c), whereas PBMC from healthy subjects showed strong responses to the peptide pool of RD15 (positive responders=83%), moderate responses to RD1501, RD1502, RD1504–RD1506 and RD1511–RD1515 (positive responders=42–56%) (Fig. 2d) and weak responses to the remaining ORFs (<40% positive responders). The statistical analysis of the results showed that positive responses induced by RD15, RD1502, RD1504, RD1505 and RD1511–RD1515 were significantly higher (P<0.05) in healthy subjects than in TB patients (Fig. 2c and d). With respect to IL-10 secretion in response to complex mycobacterial antigens, moderate responses were observed

with MT-CF and strong responses with M. bovis BCG in both TB patients (positive responders=50% and 90%, respectively) and healthy subjects (positive responders =50% and 90%, respectively) (Fig. 3a and b). However, in response to all peptide pools, IL-10 secretion by PBMC in TB patients and healthy subjects was weak (<40% positive responders), except for a moderate response to RD1508 and RD15 in TB patients and healthy subjects, respectively (positive responders=40% and 42%, respectively) (Fig. 3c and d). The analyses of IFN-γ : IL-10 ratios revealed that the complex mycobacterial antigens MT-CF and M. bovis BCG induced strong Th1 biases, which were stronger in both TB patients and healthy Celecoxib subjects in response click here to MT-CF (median IFN-γ : IL-10 ratios=162 and 225, respectively) than M.

bovis BCG (median IFN-γ : IL-10 ratios=59 and 61, respectively) (Fig. 4a and b). The peptide pool of RD1 also induced strong Th1 biases in both TB patients and healthy subjects (median IFN-γ : IL-10 ratios=57 and 34, respectively) (Fig. 4c and d). However, peptide pools of RD15 and its individual ORFs exhibited neither Th1 nor anti-inflammatory biases in TB patients (median IFN-γ : IL-10 ratios=0.8–1.0), except for a weak Th1 bias to RD1504 (median IFN-γ : IL-10 ratios=2.0) (Fig. 4c), whereas all of these peptide pools, except RD1507 (median IFN-γ : IL-10 ratios=1.0), showed Th1 biases in healthy subjects (IFN-γ : IL-10 ratios=3–54) (Fig. 4d). In particular, strong Th1 biases were observed with RD15 and RD1504 (IFN-γ : IL-10 ratios=54 and 40, respectively) (Fig. 4d), and moderate Th1 biases with RD1502, RD1505, RD1506 and RD1511–RD1514 (IFN-γ : IL-10 ratios=10–16) (Fig. 4d). Furthermore, the IFN-γ : IL-10 ratios induced by all the peptide pools, except for RD1, RD1501, RD1507 and RD1509, were significantly higher in healthy subjects than in TB patients (P<0.05) (Fig. 4c and d). In this study, cellular immune responses to the ORFs of RD15 were analyzed with PBMC obtained from pulmonary TB patients and M.